SURVEY REPORT
How Pharma Supply Chain Leaders Are Mitigating Rising Security Risks with Visibility Technology
Custom content for Tive by studioID
Pharmaceutical and life sciences supply chains are becoming increasingly complex as globalization, digitalization, and the rising prevalence of temperature-sensitive products reshape the industry. These changes, while necessary for innovation,...
The State of Risk
Pharmaceutical and life sciences supply chains are becoming increasingly complex as globalization, digitalization, and the rising prevalence of temperature-sensitive products reshape the industry. These changes, while necessary for innovation, also introduce heightened risks, including cyber attacks and physical security breaches.
A recent survey conducted by Tive, a supply chain and logistics visibility technology provider, and BioPharma Dive"s studioID revealed that most pharmaceutical executives are deeply concerned about the growing threats of theft, fraud, and attacks on their supply chains. Generally speaking, the 115 survey respondents — made up primarily of pharmaceutical, biologics, and medical device manufacturers — identified inadequate real-time visibility into the location and condition of goods as a critical vulnerability, contributing to incidents such as product tampering, theft, and compromised cold chain integrity. A significant majority of respondents (68%) strongly agree that they are "very concerned about a marked increase in theft, fraud, and/or attacks in the pharmaceutical supply chain," with another 31% somewhat agreeing.
To address these challenges, industry leaders are adopting visibility technologies that provide real-time insights into their supply chains — enabling proactive mitigation of risks. These solutions not only reduce security incidents but also improve operational efficiency, streamline reporting, provide audit trails for compliance and insurance claims, and enhance on-time, in-full delivery rates.
This report explores the sentiments toward the escalating risks facing pharmaceutical and life sciences supply chains, the visibility challenges companies are overcoming, and the transformative benefits of adopting advanced tracking and monitoring technologies.